twiist Automated Insulin Delivery (AID) System
Deka Research and Development · Decision date Jun 17, 2026
What did the FDA decide?
FDA records K261672 as a 510(k) premarket notification, with a decision dated Jun 17, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Jun 17, 2026
Regulatory record facts
- Identifier
- K261672
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Deka Research and Development
- Product code
- QFG
- Decision code
- SESE
- Decision date
- Jun 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Alternate Controller Enabled Insulin Infusion Pump.
- Applicant
- Deka Research and Development
- Product code
- QFG
- FDA device class
- 2
FDA decision timeline
K261672 received
Application receipt date recorded by FDA.
K261672 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QFG
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mint ACE PumpK263422 | Beta Bionics, Inc. | 510(k) clearance | Oct 21, 2026 | FDA |
Mint ACE PumpK260001 | Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
iLet ACE PumpK253976 | Beta Bionics, Inc. | 510(k) clearance | Apr 30, 2026 | FDA |
MiniMed Flex pumpK253743 | Medtronic MiniMed, Inc. | 510(k) clearance | Mar 12, 2026 | FDA |
| Medtronic MiniMed, Inc. | 510(k) clearance | Jan 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Deka Research and Development
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Manchester, NH
Sources and methodology
- Original FDA record: K261672
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

